Understanding Acromegaly and Gigantism: Causes, Symptoms, and Diagnosis

Acromegaly and gigantism are rare yet profoundly serious hormonal disorders caused by prolonged overproduction of growth hormone (GH). In most cases, this excess stems from a benign tumor of the pituitary gland known as a growth hormone–secreting pituitary adenoma. Although both conditions arise from the same hormonal imbalance, their effects differ dramatically depending on when the excess hormone begins.

What differentiates gigantism from acromegaly?

The key distinction lies in timing:

  • Gigantism occurs when GH hypersecretion begins in childhood or adolescence, before the closure (fusion) of the epiphyseal growth plates of long bones.

  • Acromegaly develops when GH excess begins in adulthood, after growth plates have fused.

Gigantism

When growth hormone excess occurs before epiphyseal fusion, children experience:

  • Rapid and extreme height increase

  • Abnormally long limbs

  • Enlarged hands and feet

  • Possible headaches or vision problems (due to tumor pressure)

Acromegaly

In adults, bones can no longer grow longer, but they can grow thicker. This leads to:

  • Enlargement of hands and feet

  • Coarsened facial features

  • Protruding lower jaw (prognathism)

  • Thickened lips and widened tooth spacing

  • Soft tissue swelling

Both disorders involve elevated levels of insulin-like growth factor 1 (IGF-1), the hormone stimulated by GH that drives tissue overgrowth.


Causes of Acromegaly and Gigantism

The overwhelming majority of cases are caused by a GH-secreting pituitary adenoma in the Pituitary gland.

Although these adenomas are typically benign (non-cancerous), they produce excessive GH, leading to abnormally high IGF-1 levels and progressive tissue enlargement.

Rare Causes

  • Ectopic GH secretion (outside the pituitary)

  • Excess growth hormone–releasing hormone (GHRH)

  • Genetic mutations (such as AIP or GPR101 mutations in childhood-onset cases)

While most cases are sporadic, about half of childhood-onset cases may have a genetic background.

Emerging research suggests environmental influences may also contribute, with higher rates reported in heavily industrialized areas.


Symptoms and Red Flags

Acromegaly often develops slowly over years, making early diagnosis challenging.

Common Physical Changes

  • Gradual facial changes (enlarged nose, jaw protrusion)

  • Swelling of hands and feet (rings/shoes no longer fit)

  • Thickened skin

  • Deepened voice

  • Excessive sweating

  • Joint pain and stiffness

  • Carpal tunnel syndrome

Neurological and Psychological Symptoms

  • Persistent headaches

  • Fatigue and profound weakness

  • Mood changes and depression

  • Numbness or tingling in hands


Hair Growth and Hormonal Influence

Excessive hair growth in unusual areas may occur. This can be related to:

  • Hypertrichosis – generalized or localized excessive hair growth.

  • Hormonal changes, including GH excess.

  • Other endocrine imbalances.

More information about hypertrichosis is available through the MSD Manuals.


Muscle Weakness and Hormonal Imbalance

Muscle weakness is extraordinarily common in acromegaly. Causes include:

  • Direct effects of excess GH on muscle fibers

  • Associated endocrine disorders (hypothyroidism, adrenal insufficiency)

  • Diabetes-related metabolic effects

  • Joint laxity and hypermobility

Hormonal imbalances (including thyroid and cortisol abnormalities) may also contribute to muscle twitching and neuromuscular irritability.

 

Acromegaly affects nearly every organ system.

Cardiovascular

  • Hypertension

  • Cardiomegaly (enlarged heart)

  • Increased risk of heart failure

Respiratory

  • Sleep apnea

  • Nocturnal breathing disorders

Endocrine & Metabolic

  • Elevated IGF-1

  • Altered cortisol metabolism

  • Insulin resistance and type 2 diabetes

Musculoskeletal

  • Severe joint pain

  • Bone deformities

  • Spinal curvature abnormalities

Organ Enlargement (Visceromegaly)

  • Hepatomegaly (liver)

  • Splenomegaly (spleen)

  • Enlarged kidneys

  • Thyroid enlargement (goiter)

  • Adrenal gland enlargement

Anemia is also surprisingly common among patients with acromegaly.

Additionally, some studies suggest an increased risk of certain cancers, particularly colorectal cancer.


Diagnosis

Early diagnosis is critical to reduce excess mortality.

1. IGF-1 Blood Test

Elevated IGF-1 levels strongly suggest acromegaly.

2. Growth Hormone Suppression Test

Often called the oral glucose tolerance test (OGTT), this is the diagnostic gold standard. In healthy individuals, glucose suppresses GH. In acromegaly, suppression does not occur.

3. MRI Imaging

Magnetic resonance imaging (MRI) of the pituitary identifies adenomas and evaluates tumor size.

Reputable clinical information is available from the Mayo Clinic.


Prevalence

  • Acromegaly: ~11 cases per million person-years

  • Gigantism: ~8 cases per million person-years

Acromegaly is more commonly diagnosed than gigantism.


Management and Treatment

Treatment aims to normalize GH and IGF-1 levels and reduce tumor mass.

Surgical Treatment

Transsphenoidal surgery to remove the pituitary adenoma is the primary therapy.

Medical Therapy

  • Somatostatin analogs (e.g., octreotide)

  • Dopamine agonists

  • GH receptor antagonists

Radiation Therapy

Used if surgery and medication are insufficient.

Ongoing monitoring of GH and IGF-1 is essential.


Dietary and Lifestyle Considerations

Patients are advised to:

  • Limit saturated fats

  • Reduce added sugars

  • Restrict excess salt

  • Avoid excessive alcohol

  • Maintain cardiovascular health

Weight control and sleep apnea management are especially important.


Conclusion

Acromegaly and gigantism are rare, typically tumor-driven disorders caused by excess growth hormone and IGF-1. The distinction between the two lies in when hormone excess begins:

  • Gigantism: Before epiphyseal plate closure (childhood)

  • Acromegaly: After plate closure (adulthood)

Though rare, these disorders carry serious cardiovascular, metabolic, and musculoskeletal consequences. Early recognition, accurate hormonal testing, and appropriate surgical and medical treatment dramatically improve outcomes.

References

Genetics of Gigantism and Acromegaly https://pmc.ncbi.nlm.nih.gov/articles/PMC5154831/

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9    

Comments

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

Dysferlin Protein: Key Roles, Genetic Locations